Artificial intelligence can improve patients’ experience in decentralized clinical trials
[ad_1] The clinical trials industry is undergoing a rapid transition toward decentralization, whereby some or all health assessments are performed remotely in participants’ homes instead of in medical centers. This transition was accelerated by the need to continue running clinical trials during the COVID-19 pandemic. A decade ago, researchers collected initial evidence indicating that in-home … Read more